“Bufalin inhibits the growth and epithelial to mesenchymal transition of human gastric cancer cells via modulation of MEK/ERK pathway” (2021) Bangladesh Journal of Pharmacology, 16(1), pp. 27–33. doi:10.3329/bjp.v16i1.50548.